Publicaciones en colaboración con investigadores/as de Harvard Medical School (3)

2024

  1. Angiotensin Receptor-Neprilysin Inhibition in Patients With STEMI vs NSTEMI

    Journal of the American College of Cardiology, Vol. 83, Núm. 9, pp. 904-914

2023

  1. Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study

    Diabetes and Metabolism, Vol. 49, Núm. 2

2021

  1. The ‘Peptide for Life’ Initiative: a call for action to provide equal access to the use of natriuretic peptides in the diagnosis of acute heart failure across Europe

    European Journal of Heart Failure, Vol. 23, Núm. 9, pp. 1432-1436